✦ LIBER ✦

Aclarubicin in the treatment of relapsed or resistant acute myelogenous leukaemia: a phase II trial

✍ Scribed by S. A. Evensen; F. Wisøff; E. Müller; I. Talstad; A. Waage; L. Johansen

Book ID: 114790677
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 240 KB
Volume: 38
Category: Article
ISSN: 0902-4441
DOI: 10.1111/j.1600-0609.1987.tb00021.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Aclarubicin (aclacinomycin A) in the tre

Aclarubicin (aclacinomycin A) in the treatment of relapsing acute leukaemias

✍ Mitrou, P.S.; Kuse, R.; Anger, H.; Herrmann, R.; Bonfet, B.; Pralle, H.; Thiel, 📂 Article 📅 1985 🏛 Elsevier Science ⚖ 499 KB

Aclarubicin in the treatment of acute no

Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial

✍ J. Pedersen-Bjergaard; N.I. Nissen; H. Brincker; J. Ellegaard; A. Drivsholm; L. 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB

A phase I-II trial of 4'-deoxydoxorubici

A phase I-II trial of 4'-deoxydoxorubicin (esorubicin) in refractory or relapsed acute leukemia

✍ Dutcher, Janice P; Riggs, Charles E; Strauman, Janice J; Link, Brian; Wiernik, P 📂 Article 📅 1989 🏛 Nature Publishing Group 🌐 English ⚖ 389 KB

Oral idarubicin in the treatment of acut

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia

✍ S. T. A. Malik; J. Tucker; A. Z. S. Rohatiner; W. Brace; T. A. Lister 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per

Combination of aclarubicin and etoposide

Combination of aclarubicin and etoposide for the treatment of advanced acute myeloid leukemia: results of a prospective multicenter phase II trial

✍ Kern, W; Braess, J; Grote-Metke, A; Kuse, H; Fuchs, R; Hossfeld, D K; Reichle, A 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB

A phase II trial of high-dose imatinib m

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: The AFR-15 trial

✍ Patrice Chevallier; Mathilde Hunault-Berger; Fabrice Larosa; Charles Dauriac; Ri 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 101 KB